Join the 'Mycobacterium avium-intracellulare - Prophylaxis' group to help and get support from people like you.
Mycobacterium avium-intracellulare - Prophylaxis News
Posted 1 Jul 2015 by Drugs.com
WEDNESDAY, July 1, 2015 – Even after the advent of powerful medications for suppressing HIV, a new study finds that more than one-third of people in San Francisco who were diagnosed with an AIDS-related infection died within five years. "The main cause of mortality arises from people stopping treatment entirely," said Dr. Robert Grant, a professor at the University of California, San Francisco, who reviewed the findings but was not involved in the research. When HIV treatment lapses, so-called "opportunistic" infections and illnesses can arise, posing a real threat to patients' health, he explained. The bottom line, according to Grant, is that there is still "a long way to go" in prolonging the lives of Americans with HIV/AIDS. The new study was led by Dr. Sandra Schwarcz, associate professor of epidemiology and biostatistics at the University of California, San Francisco. She and her ... Read more
Related support groups: Harvoni, HIV Infection, Tamiflu, Atripla, Sovaldi, Pre-Exposure Prophylaxis, Incivek, Truvada, Stribild, Triumeq, Complera, Baraclude, Victrelis, Mycobacterium avium-intracellulare - Treatment, Sofosbuvir, Mycobacterium avium-intracellulare, Oseltamivir, Viread, Kaletra, Entecavir